|
| Status |
Public on Apr 26, 2022 |
| Title |
Epigenetic reversal of lineage plasticity enhances responsiveness to anti-GD2 therapy in neuroblastoma |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
35817829 |
| NIH grant(s) |
| Grant ID |
Grant title |
Affiliation |
Name |
| P01 CA217959 |
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance |
CHILDREN'S HOSPITAL OF PHILADELPHIA |
JOHN M MARIS |
| F32 CA261035 |
Elucidating the Role of Epigenetic Plasticity in anti-GD2 Immunotherapy Response |
DANA-FARBER CANCER INSTITUTE |
Nathaniel Mabe |
| R35 CA210030 |
Integrating Transforming Approaches to Identify and Target New Vulnerabilities in Cancer |
DANA-FARBER CANCER INSTITUTE |
Kimberly Stegmaier |
|
| |
| Submission date |
Jul 20, 2021 |
| Last update date |
Jul 26, 2022 |
| Contact name |
Nathaniel Wesley Mabe |
| E-mail(s) |
nathanielw_mabe@dfci.harvard.edu
|
| Organization name |
Dana-Farber Cancer Institute
|
| Department |
Pediatric Oncology
|
| Lab |
Kimberly Stegmaier
|
| Street address |
450 Brookline Avenue
|
| City |
Boston |
| State/province |
Massachusetts |
| ZIP/Postal code |
02215 |
| Country |
USA |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (40)
|
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE180509 |
Epigenetic reversal of lineage plasticity enhances responsiveness to anti-GD2 therapy in neuroblastoma [ATAC-seq SK-N-AS] |
| GSE180512 |
Epigenetic reversal of lineage plasticity enhances responsiveness to anti-GD2 therapy in neuroblastoma [RNA-seq SK-N-AS] |
| GSE180514 |
Epigenetic reversal of lineage plasticity enhances responsiveness to anti-GD2 therapy in neuroblastoma [RNA-seq kelly cells] |
| GSE180515 |
Epigenetic reversal of lineage plasticity enhances responsiveness to anti-GD2 therapy in neuroblastoma [RNA-seq SKNBE2 or KPNYN] |
| GSE196861 |
Epigenetic reversal of lineage plasticity enhances responsiveness to anti-GD2 therapy in neuroblastoma [ChIP-Seq] |
|
| Relations |
| BioProject |
PRJNA748442 |
Less...
More...